Alivus Life Sciences Limited (NSE:ALIVUS)
India flag India · Delayed Price · Currency is INR
1,081.15
+19.50 (1.84%)
At close: Mar 28, 2025, 3:30 PM IST

Alivus Life Sciences Revenue

Alivus Life Sciences had revenue of 6.42B INR in the quarter ending December 31, 2024, with 12.05% growth. This brings the company's revenue in the last twelve months to 22.74B, down -3.97% year-over-year. In the fiscal year ending March 31, 2024, Alivus Life Sciences had annual revenue of 22.83B with 5.64% growth.

Revenue (ttm)
22.74B
Revenue Growth
-3.97%
P/S Ratio
5.83
Revenue / Employee
11.29M
Employees
2,014
Market Cap
132.48B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202422.83B1.22B5.64%
Mar 31, 202321.61B380.06M1.79%
Mar 31, 202221.23B2.38B12.63%
Mar 31, 202118.85B3.48B22.63%
Mar 31, 202015.37B6.51B73.43%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition